knowledge -WSS

knowledge

author：entertainment 2025-09-06 03:40:00 - browse：81

Photo illustration based on photograph of The University of Texas MD Anderson Cancer Center in Houston, Texas in 2022 — Photo illustration: STAT; Photo: Adobe

Prominent immunologist and oncologist Padmanee Sharma defended herself in court on Friday against a lawsuit that alleges she threatened to undermine a junior faculty member’s career, made defamatory comments about the younger scientist, and attempted to take credit for work that she didn’t do.

In legal filings submitted to the Harris County District Court, Sharma said that she made substantial contributions to an immunotherapy project that were ignored, and that a third-party assessment commissioned by MD Anderson Cancer Center concluded Sharma should be given credit for her role. Sharma had previously issued a general denial of the allegations against her and claimed immunity from the suit as a government employee. As part of the University of Texas, MD Anderson is a state institution.

The filing, which was submitted by Texas Attorney General Ken Paxton and lawyers in his office, also argued that the junior researcher’s lawsuit should be made against MD Anderson, not Sharma, and asked the court to dismiss the suit if it is not amended within 30 days. “Dr. Sharma is not a proper party to this lawsuit; only MDACC is,” the filing states. “This lawsuit is about proper accreditation in scientific literature for research performed at MDACC by MDACC faculty.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： As demand for Covid shots wanes, Moderna seeks its next success

WSS

Louisiana bill approved classifying abortion pills as controlled substances

Supreme Court strikes down use of affirmative action

Cancer drug shortages should be causing more outrage

Moonlake's readout produced a cash windfall. Risks remain

Beyond aggravation: Constipation is an American epidemic

How to save PrEP access — and even expand it

hotspot

knowledge

hotspot

United colonoscopy coverage change 'may cost lives,' doctors say

23andMe had bad news about my health. I wish a person had delivered it

Moonlake's readout produced a cash windfall. Risks remain

Drug repurposing or repositioning? The language matters

After affirmative action ruling, medical educators look to 'holistic review'

Guardant Health colon cancer test endorsed by FDA advisory panel

Walensky prepares to leave CDC — and Congress — behind

Pharma’s losing bet in New Jersey

Activists slam private health insurers over coverage restrictions

Trump demands the U.S. pay no more for drugs than other countries … again

knowledge

Stroke rates rising, especially in working

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Bright Health sells Medicare Advantage business to Molina

Why some fertility treatments produce more boy babies

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

J&J reports mixed data on next

focus

knowledge

hotspot

entertainment